Stock listing
VNRX Stock Price, News, Filings & Events — Volitionrx Limited
Selected listing: VNRX · AMEX · USD · US
This page tracks Volitionrx Limited's VNRX:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VNRX:AMEX. VNRX:AMEX is the stock-level entry point for investors researching Volitionrx Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. VolitionRx Limited (ticker: VNRX) is a public company based in the United States with a market capitalization of approximately $12 million. The company focuses on developing innovative diagnostic tests for various diseases, leveraging its proprietary technology. VolitionRx aims to improve healthcare outcomes through early detection and diagnosis.
- Ticker
- VNRX:AMEX
- Asset type
- Stock
- Market cap
- $5.8M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- AMEX
- Currency
- USD
Volitionrx Limited VNRX:AMEX stock context
This page tracks Volitionrx Limited's VNRX:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VNRX:AMEX. VNRX:AMEX is the stock-level entry point for investors researching Volitionrx Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. VolitionRx Limited (ticker: VNRX) is a public company based in the United States with a market capitalization of approximately $12 million. The company focuses on developing innovative diagnostic tests for various diseases, leveraging its proprietary technology. VolitionRx aims to improve healthcare outcomes through early detection and diagnosis.
Latest news from Volitionrx Limited
Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
August 26, 2026
VolitionRx : Announces Second Quarter 2026 Financial Results and Business Update
August 13, 2026
Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
August 12, 2026
VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update
August 12, 2026
Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology
August 5, 2026
Volitionrx Limited earnings calls
VolitionRX Limited (VNRX) Q2 2026 Earnings Call
August 14, 2026 · Replay with transcript and chapters
VolitionRX Limited (VNRX) Q1 2026 Earnings Call
May 15, 2026 · Replay with transcript and chapters
VolitionRX Limited (VNRX) Q4 2025 Earnings Call
April 1, 2026 · Replay with transcript and chapters
VolitionRX Limited (VNRX) Q3 2025 Earnings Call
November 14, 2025 · Replay with transcript and chapters
VolitionRX Limited (VNRX) Q2 2025 Earnings Call
August 15, 2025 · Replay with transcript and chapters
VolitionRX Limited (VNRX) Q1 2025 Earnings Call
May 16, 2025 · Replay with transcript and chapters
Research Volitionrx Limited
Volitionrx Limited investor report
Review AI stock analysis and investor report context for VNRX:AMEX.
Volitionrx Limited company profile
View the public company page for Volitionrx Limited on 6ix.
Volitionrx Limited news
Read company news and market updates connected to Volitionrx Limited.
Volitionrx Limited investor events
Find investor webinars, events, and replay context for Volitionrx Limited.